Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo
about
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviourA case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibilityTumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibilityAssociation of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo PathogenesisTumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibilityAssociation between interferon-γ +874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis.Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study.Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo.CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study.Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.Type I interferon signature in the initiation of the immune response in vitiligo
P2860
Q27002574-5788DBB9-6C52-490F-A653-9EBE6E48974AQ33897820-E50AF026-FED1-4647-9304-7C7FEDB303E0Q34183603-833712F7-81DF-4A48-949C-32F68E2D8948Q35060678-E03425D6-09CA-4F19-B1D3-9ABE89902421Q36084225-4C547CF2-BCAE-4A4F-8A9B-9F4664767FDEQ36094915-28B59A0C-93F0-4643-AE32-ACBA51ECA0A5Q37192618-A0F1D2AA-4CFC-42C3-87B3-4A12F21DE076Q38679171-2C6DF1E2-785D-4CD9-9678-EFBCF5341212Q40072169-7D5F9DF3-C0CA-4014-B847-78EA2D9927CFQ42460159-3CCD46B6-CA0C-4D3C-B38F-47D957E29552Q45980503-0917D770-9C9F-462D-B827-D511E2F328D1Q46490608-942D75BD-9700-40DE-8C52-04AE6953AC88Q48377795-BD4FB717-215F-47E8-8725-5F2DDF1E2BD3Q51075988-EA4E02F7-3761-4661-B727-950E1CF0DA78Q56996562-4CD4D5CA-5D99-43F1-A006-E63B2979EFD2
P2860
Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Involvement of interferon-gamm ...... ession of generalized vitiligo
@en
Involvement of interferon-gamm ...... ssion of generalized vitiligo.
@nl
type
label
Involvement of interferon-gamm ...... ession of generalized vitiligo
@en
Involvement of interferon-gamm ...... ssion of generalized vitiligo.
@nl
prefLabel
Involvement of interferon-gamm ...... ession of generalized vitiligo
@en
Involvement of interferon-gamm ...... ssion of generalized vitiligo.
@nl
P2093
P2860
P356
P1476
Involvement of interferon-gamm ...... ession of generalized vitiligo
@en
P2093
Bela J Shah
Kriti Shah
Naresh C Laddha
P2860
P304
P356
10.1089/JIR.2012.0171
P577
2013-06-18T00:00:00Z